
CAS 956590-23-1
:UNBS5162
Description:
UNBS5162, with the CAS number 956590-23-1, is a synthetic compound that has garnered attention for its potential applications in medicinal chemistry, particularly as an anti-cancer agent. It belongs to a class of compounds known as small molecule inhibitors, which target specific proteins involved in cancer cell proliferation and survival. The substance exhibits a unique chemical structure that contributes to its biological activity, often characterized by the presence of specific functional groups that enhance its binding affinity to target proteins. UNBS5162 has shown promise in preclinical studies, demonstrating efficacy in inhibiting tumor growth and inducing apoptosis in various cancer cell lines. Its pharmacokinetic properties, including absorption, distribution, metabolism, and excretion, are critical for determining its therapeutic potential and safety profile. Ongoing research aims to further elucidate its mechanism of action and optimize its chemical properties for improved efficacy and reduced side effects in clinical applications. As with any investigational compound, comprehensive studies are essential to fully understand its characteristics and potential therapeutic benefits.
Formula:C17H18N4O3
Synonyms:- [2-[2-(dimethylamino)ethyl]-1,3-dioxobenzo[de]isoquinolin-5-yl]urea
- Uunbs-5162
- 1-(2-(2-(Dimethylamino)ethyl)-1,3-dioxo-2,3-dihydro-1H-benzo[de]isoquinolin-5-yl)urea
- UNBS 5162; UNBS-5162
- UNBS-5162, >=98%
- UNBS-5162
- CS-1759
- Urea, N-[2-[2-(dimethylamino)ethyl]-2,3-dihydro-1,3-dioxo-1H-benz[de]isoquinolin-5-yl]-
- 1-(2-(2-(dimethylamino)ethyl)-1,3-dioxo-2,3-dihydro-1H-benzo[de]isoquinolin-5-yl)urea UNBS-5162
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 4 products.
UNBS5162
CAS:UNBS5162 (UNBS-5162) is a novel naphthalimide that decreases CXCL chemokine expression in experimental prostate cancers.Formula:C17H18N4O3Purity:98.37% - 99.97%Color and Shape:SolidMolecular weight:326.35UNBS5162
CAS:<p>UNBS5162 is a naphthalimide that has been shown to be dose-limiting in the treatment of cancer. It has been shown to inhibit the growth of tumors in mice, and also to induce apoptosis. The mechanism of action appears to be related to DNA intercalation and hydrogen bonding interactions. UNBS5162 binds selectively with double-stranded DNA, which may lead to inhibition of DNA replication and transcription. This compound has been shown to have anti-tumor activity in a variety of solid tumor models, including lymphoma cells.</p>Formula:C17H18N4O3Purity:Min. 95%Molecular weight:326.35 g/mol



